Lesaffre, a manufacturer of food products, offered to acquire NattoPharma for $75m, a nutraceutical company that develops and sells products containing natural vitamin K2. NattoPharma is in favor of the offer, with its board of directors unanimously deciding to recommend NattoPharma shareholders to accept the voluntary cash offer. “The industrial rationale for a combination of the two companies is substantial, and we regard Lesaffre as an optimal acquirer of the company,” Frode Marc Bohan, NattoPharma Chairman of the Board.